German pharmaceutical company Bayer was ordered to pay $1.56 billion in the Roundup case in the USA.
Bayer continues to lose lawsuits filed in the USA by those who claim that the glyphosate-containing pesticide called Roundup is an important factor that triggers cancer.
A jury in the US state of Missouri court on Friday ordered the German company to pay $1.56 billion to four plaintiffs who claimed that Bayer’s weed killer product Roundup caused harm, including cancer.
HE LOST THE FOURTH CASE
Bayer lost the fourth lawsuit filed in the USA over the pesticide containing glyphosate called Roundup.
The jury also found that Bayer was liable for failing to warn the plaintiffs about the potential dangers of using Roundup.
The decision is expected to increase investor pressure on Bayer to change its legal strategy.
On the other hand, Bayer announced today that it canceled the clinical trial of the drug Asundexian.
IT LOST NEARLY 20 PERCENT OF VALUE IN THE STOCK EXCHANGE
Bayer’s shares lost nearly 20 percent of their value in the stock market today.
After Bayer acquired the US agricultural company Monsanto for 63 billion dollars in 2018, it was sentenced to pay billions of dollars in fines and compensation in the lawsuits filed by those who claimed that the glyphosate-containing pesticide developed by this company, called Roundup, was an important element that triggered the formation of cancer. .
While Bayer denied the claims about glyphosate, in 2015 the International Agency for Research on Cancer (IARC) classified glyphosate as carcinogenic.
Bayer announced that it reached a settlement in the lawsuits filed against it in the USA in 2020 and that $10.9 billion would be paid to the plaintiffs. Despite the agreement, the company faces approximately 50 thousand lawsuits related to Roundup.